Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Treace Medical Concepts (TMCI) Equity Ratio (2020 - 2025)

Treace Medical Concepts (TMCI) has disclosed Equity Ratio for 6 consecutive years, with 0.46 as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Equity Ratio fell 11.88% year-over-year to 0.46, compared with a TTM value of 0.46 through Dec 2025, down 11.88%, and an annual FY2025 reading of 0.46, down 11.88% over the prior year.
  • Equity Ratio was 0.46 for Q4 2025 at Treace Medical Concepts, up from 0.45 in the prior quarter.
  • Across five years, Equity Ratio topped out at 0.72 in Q2 2021 and bottomed at 0.02 in Q1 2021.
  • Average Equity Ratio over 5 years is 0.51, with a median of 0.52 recorded in 2024.
  • The sharpest move saw Equity Ratio soared 3460.77% in 2021, then tumbled 43.82% in 2022.
  • Year by year, Equity Ratio stood at 0.66 in 2021, then tumbled by 42.41% to 0.38 in 2022, then surged by 43.86% to 0.55 in 2023, then decreased by 5.03% to 0.52 in 2024, then dropped by 11.88% to 0.46 in 2025.
  • Business Quant data shows Equity Ratio for TMCI at 0.46 in Q4 2025, 0.45 in Q3 2025, and 0.47 in Q2 2025.